• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过磁共振成像的定量容积分析识别胶质母细胞瘤的生存亚型。

Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI.

作者信息

Zhang Zhe, Jiang Haihui, Chen Xuzhu, Bai Jiwei, Cui Yong, Ren Xiaohui, Chen Xiaolin, Wang Junmei, Zeng Wei, Lin Song

机构信息

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.

出版信息

J Neurooncol. 2014 Aug;119(1):207-14. doi: 10.1007/s11060-014-1478-2. Epub 2014 May 15.

DOI:10.1007/s11060-014-1478-2
PMID:24828264
Abstract

This study was to project a powerful volumetric-related parameter on magnetic resonance imaging (MRI) for classifying patients with glioblastoma multiforme (GBM) into distinct subgroups objectively. The preoperative MRIs of 147 patients with primary GBM were analyzed. Volumetric-related parameters, including V1 (tumor volume), V2 (peritumoral T2/FLAIR hyperintense volume) and V2/V1 (the volume ratio), were estimated by an ellipsoid model. Log-rank analysis and Cox regression methods were used to compare Kaplan-Meier plots and identified prognostic parameters. Log-rank analysis revealed that V1 and V2 were correlated with survival, but the P value was marginally significant (P = 0.082, P = 0.091, for progression-free survival [PFS]; P = 0.120, P = 0.073, for overall survival [OS], respectively). V2/V1 was a potential prognostic factor for both PFS and OS (P < 0.001 and P < 0.001, respectively). Cox regression analysis documented that higher V2/V1 (ratio ≥ 7.0) was independent unfavorable prognostic factor. The odd ratio (OR) of higher V2/V1 was 2.662 (95 % confidence interval [CI], 1.782-3.975; P < 0.001) for PFS and 3.450 (95 % CI, 2.079-5.725; P < 0.001) for OS, respectively. The volumetric-related parameters of V1, V2 and V2/V1 were helpful for predicting the prognosis of patients with GBM. V2/V1 was a more comprehensive and systematic prognostic factor in GBM patient, especially for those with small tumor but large peritumoral T2 hyperintense or large tumor but small peritumoral T2 hyperintense.

摘要

本研究旨在通过磁共振成像(MRI)得出一个与体积相关的重要参数,以便将多形性胶质母细胞瘤(GBM)患者客观地分为不同亚组。对147例原发性GBM患者的术前MRI进行了分析。采用椭球体模型估算与体积相关的参数,包括V1(肿瘤体积)、V2(瘤周T2/液体衰减反转恢复序列高信号体积)和V2/V1(体积比)。采用对数秩分析和Cox回归方法比较Kaplan-Meier曲线并确定预后参数。对数秩分析显示,V1和V2与生存率相关,但P值接近显著水平(无进展生存期[PFS]时,P = 0.082,P = 0.091;总生存期[OS]时,P = 0.120,P = 0.073)。V2/V1是PFS和OS的潜在预后因素(分别为P < 0.001和P < 0.001)。Cox回归分析表明,较高的V2/V1(比值≥7.0)是独立的不良预后因素。较高V2/V1的比值比(OR)在PFS时为2.662(95%置信区间[CI],1.782 - 3.975;P < 0.001),在OS时为3.450(95%CI,2.079 - 5.725;P < 0.0

相似文献

1
Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI.通过磁共振成像的定量容积分析识别胶质母细胞瘤的生存亚型。
J Neurooncol. 2014 Aug;119(1):207-14. doi: 10.1007/s11060-014-1478-2. Epub 2014 May 15.
2
Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.对胶质母细胞瘤患者基线增强肿瘤体积的定量容积评估作为一种影像学生物标志物可预测总生存期。
Acta Radiol. 2021 Sep;62(9):1200-1207. doi: 10.1177/0284185120953796. Epub 2020 Sep 16.
3
Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.表观扩散系数和肿瘤体积测量有助于对接受贝伐单抗治疗的复发性多形性胶质母细胞瘤患者的无进展生存期进行分层。
Neuroradiol J. 2019 Aug;32(4):241-249. doi: 10.1177/1971400919847184. Epub 2019 May 8.
4
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.在预测新诊断胶质母细胞瘤的生存率方面,临床参数比基于扩散和灌注的MRI参数更为重要。
Neuro Oncol. 2016 Dec;18(12):1673-1679. doi: 10.1093/neuonc/now122. Epub 2016 Jun 13.
5
Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.多尺度放射组学分析预测胶质母细胞瘤患者的生存情况。
Med Biol Eng Comput. 2018 Dec;56(12):2287-2300. doi: 10.1007/s11517-018-1858-4. Epub 2018 Jun 19.
6
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.癌症基因组图谱胶质母细胞瘤患者队列的多中心影像结果研究:总生存期和无进展生存期的影像预测因素
Neuro Oncol. 2015 Nov;17(11):1525-37. doi: 10.1093/neuonc/nov117. Epub 2015 Jul 22.
7
Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.术前胶质母细胞瘤患者瘤周 T2 高信号异质性分析:基于 MRI 的放射组学的预后价值。
Eur J Radiol. 2019 Nov;120:108642. doi: 10.1016/j.ejrad.2019.108642. Epub 2019 Sep 14.
8
Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions.动态对比增强 MRI 衍生药代动力学变量在胶质母细胞瘤患者中的预后价值:增强病变和非增强 T2 高信号强度病变的分析。
Korean J Radiol. 2020 Jun;21(6):707-716. doi: 10.3348/kjr.2019.0629.
9
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.利用解剖磁共振图像的定量容积分析鉴定胶质母细胞瘤的间充质分子亚型。
Neuro Oncol. 2013 May;15(5):626-34. doi: 10.1093/neuonc/not008. Epub 2013 Feb 26.
10
Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.使用治疗前和治疗后瘤周灌注成像参数对新诊断的多形性胶质母细胞瘤患者进行生存分析。
J Neurooncol. 2014 Nov;120(2):361-70. doi: 10.1007/s11060-014-1560-9. Epub 2014 Aug 7.

引用本文的文献

1
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.基于机器学习的胶质母细胞瘤预后亚组分析:一项多中心研究。
Neuro Oncol. 2025 May 15;27(4):1102-1115. doi: 10.1093/neuonc/noae260.
2
Prediction of prognosis in glioblastoma with radiomics features extracted by synthetic MRI images using cycle-consistent GAN.基于循环一致性生成对抗网络提取的合成 MRI 图像放射组学特征预测胶质母细胞瘤预后。
Phys Eng Sci Med. 2024 Sep;47(3):1227-1243. doi: 10.1007/s13246-024-01443-8. Epub 2024 Jun 17.
3
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study.

本文引用的文献

1
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.利用解剖磁共振图像的定量容积分析鉴定胶质母细胞瘤的间充质分子亚型。
Neuro Oncol. 2013 May;15(5):626-34. doi: 10.1093/neuonc/not008. Epub 2013 Feb 26.
2
Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution.1p/19q 完全缺失、IDH1 突变和 MGMT 启动子甲基化在神经胶质瘤中的意义:谨慎使用。
Mod Pathol. 2013 Jul;26(7):922-9. doi: 10.1038/modpathol.2012.166. Epub 2013 Feb 22.
3
Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.
单灶性胶质母细胞瘤患者队列中的肿瘤大小与总生存期:单变量和多变量预后建模及重采样研究
Cancers (Basel). 2024 Mar 27;16(7):1301. doi: 10.3390/cancers16071301.
4
Association of MRI Volume Parameters in Predicting Patient Outcome at Time of Initial Diagnosis of Glioblastoma.胶质母细胞瘤初诊时MRI体积参数与预测患者预后的相关性
Brain Sci. 2023 Nov 10;13(11):1579. doi: 10.3390/brainsci13111579.
5
Efficacy of Location-Based Features for Survival Prediction of Patients With Glioblastoma Depending on Resection Status.基于位置特征对不同切除状态的胶质母细胞瘤患者进行生存预测的效能
Front Oncol. 2021 Jul 6;11:661123. doi: 10.3389/fonc.2021.661123. eCollection 2021.
6
F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors.长期异柠檬酸脱氢酶野生型弥漫性胶质瘤幸存者的F-FET PET摄取特征
Cancers (Basel). 2021 Jun 24;13(13):3163. doi: 10.3390/cancers13133163.
7
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features.通过分析临床、影像学和分子特征鉴别异柠檬酸脱氢酶野生型胶质母细胞瘤中的假性进展与真正早期进展
Front Oncol. 2021 Apr 20;11:627325. doi: 10.3389/fonc.2021.627325. eCollection 2021.
8
Robustness of Radiomics for Survival Prediction of Brain Tumor Patients Depending on Resection Status.基于切除状态的脑肿瘤患者生存预测的影像组学稳健性
Front Comput Neurosci. 2019 Nov 8;13:73. doi: 10.3389/fncom.2019.00073. eCollection 2019.
9
Supratentorial high-grade astrocytoma with leptomeningeal spread to the fourth ventricle: a lethal dissemination with dismal prognosis.幕上高级别星形细胞瘤伴软脑膜播散至第四脑室:致命性播散,预后极差。
J Neurooncol. 2019 Apr;142(2):253-261. doi: 10.1007/s11060-018-03086-8. Epub 2019 Jan 2.
10
Monitoring Radiation Treatment Effects in Glioblastoma: FLAIR Volume as Significant Predictor of Survival.监测胶质母细胞瘤的放射治疗效果:FLAIR体积作为生存的重要预测指标
Tomography. 2017 Sep;3(3):131-137. doi: 10.18383/j.tom.2017.00009.
端粒酶相关参数在胶质母细胞瘤中的预后意义:患者年龄的影响。
Neuro Oncol. 2013 Apr;15(4):423-32. doi: 10.1093/neuonc/nos329. Epub 2013 Feb 7.
4
A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature.一种新型的体积年龄-KPS(VAK)胶质母细胞瘤分类方法确定了一种预后相关的 microRNA-基因特征。
PLoS One. 2012;7(8):e41522. doi: 10.1371/journal.pone.0041522. Epub 2012 Aug 3.
5
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.脑胶质瘤患者的容积和 MGMT 参数:生存分析。
BMC Cancer. 2012 Jan 3;12:3. doi: 10.1186/1471-2407-12-3.
6
A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival.对原发性胶质母细胞瘤中囊变特征作为生存预后因素的评价。
J Neurosurg. 2011 Oct;115(4):754-9. doi: 10.3171/2011.5.JNS11128. Epub 2011 Jul 15.
7
Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab.贝伐珠单抗治疗复发性胶质母细胞瘤的常规 MRI 反应的定量容积分析。
Neuro Oncol. 2011 Apr;13(4):401-9. doi: 10.1093/neuonc/noq206. Epub 2011 Feb 15.
8
Scale to predict survival after surgery for recurrent glioblastoma multiforme.预测复发性多形性胶质母细胞瘤手术后生存的评分。
J Clin Oncol. 2010 Aug 20;28(24):3838-43. doi: 10.1200/JCO.2010.30.0582. Epub 2010 Jul 19.
9
Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology.评估肿瘤学中预后和预测生物标志物医学效用的临床试验设计。
Per Med. 2010 Jan 1;7(1):33-47. doi: 10.2217/pme.09.49.
10
Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.单发转移瘤与高级别胶质瘤的形态计量分析及灌注加权 MRI 影像学鉴别诊断。
Clin Radiol. 2010 Jan;65(1):15-20. doi: 10.1016/j.crad.2009.09.005.